FDA Approves a New Option for Certain Adults After Stroke

Reporting by U.S. Food and Drug Administration · November 9, 2026

The FDA has approved Sunharbo alongside antiplatelet treatment for certain adults after a recent stroke or high-risk transient ischemic attack. The agency describes the trial evidence and bleeding risks, with eligibility narrower than every patient needing stroke prevention care.

This is HUB News’s original summary. Read the complete report at U.S. Food and Drug Administration.